Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost effectively than the traditional biotech model.
![](https://directorstalk.net/wp-content/uploads/2023/12/Poolbeg-Pharma-plc-300x300.png)
Breakthrough cancer treatments set to redefine oncology in 2025
Experience the transformative era in cancer treatment strategies! Learn about groundbreaking therapies, innovative drug designs, and major advancements in oncology by 2025.